Covered recipient · General Payments record
MOHMAD AJAZ BULBUL
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$7,805.25
- Reported across 343 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,352.01 | 77 |
| Education | $77.97 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $283.92 | 9 |
| PFIZER INC. | $266.73 | 9 |
| Genentech, Inc. | $250.16 | 2 |
| Acerta Pharma LLC | $224.00 | 6 |
| GlaxoSmithKline, LLC. | $194.66 | 4 |
| Janssen Biotech, Inc. | $134.28 | 7 |
| Rigel Pharmaceuticals, Inc. | $123.24 | 1 |
| ABBVIE INC. | $105.04 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $84.57 | 4 |
| SEAGEN INC. | $77.97 | 1 |
| Genentech USA, Inc. | $77.92 | 4 |
| Regeneron Healthcare Solutions, Inc. | $71.71 | 3 |
| Astellas Pharma US Inc | $59.39 | 4 |
| Tempus AI, Inc | $59.27 | 1 |
| Gilead Sciences, Inc. | $54.60 | 3 |
| Amgen Inc. | $53.25 | 3 |
| Alnylam Pharmaceuticals Inc. | $41.48 | 2 |
| E.R. Squibb & Sons, L.L.C. | $36.82 | 2 |
| Pharmacosmos Therapeutics Inc. | $33.83 | 2 |
| MENARINI SILICON BIOSYSTEMS, INC. | $31.94 | 1 |
| Daiichi Sankyo Inc. | $25.66 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $25.48 | 1 |
| SERVIER PHARMACEUTICALS LLC | $23.91 | 1 |
| TAIHO ONCOLOGY, INC. | $20.79 | 1 |
| Smith & Nephew, Inc. | $20.11 | 1 |
| GENZYME CORPORATION | $19.32 | 1 |
| EISAI INC. | $15.23 | 1 |
| Novocure Inc. | $14.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (78)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.